For the 30 percent of clinically depressed people who don’t respond to medication, the U.S. Food and Drug Administration recently approved a new, noninvasive treatment option. With NeuroStar TMS, a wand held over the head delivers highly focused magnetic pulses to a part of the brain that’s been linked to depression. A typical course of treatment would involve 40-minute sessions at a psychiatrist’s office five times a week for four to six weeks. In two clinical trials, roughly half of patients said that their symptoms were reduced by at least 50 percent.
Courtesy of Neuronetics
Product: NeuroStar TMS Therapy system
Cost: Approximately $6,000 for a course of 20 to 30 sessions, depending on the provider
Other products in this section:
Become an Insider to get the story behind the story — and before anyone else.
CRISPR experts are calling for a global moratorium on heritable gene editing
Some of the biggest names in gene editing want to stop anyone from playing around with cells that pass on changes to the next generation.
23andMe thinks polygenic risk scores are ready for the masses, but experts aren’t so sure
A new genetic test that estimates your risk for diabetes is probably less useful than standing on a scale.
There’s probably another planet in our solar system
Laying out two decades of evidence for the mysterious “Planet 9,” a team of astronomers predicts that if it exists, it’s likely to be discovered within the decade.